Filter your results
- 3
- 3
- 3
- 1
- 2
- 3
- 3
- 1
- 1
- 3
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Advancing human induced pluripotent stem cell‐derived blood‐brain barrier models for studying immune cell interactionsFASEB Journal, 2020, 34 (12), pp.16693-16715. ⟨10.1096/fj.202001507RR⟩
Journal articles
hal-03126912v1
|
||
|
High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitroJournal of Neuroinflammation, 2023, ⟨10.1186/s12974-023-02797-8⟩
Journal articles
hal-04104383v1
|
||
|
Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitroFluids and Barriers of the CNS, 2020, 17, pp.3. ⟨10.1186/s12987-019-0165-2⟩
Journal articles
hal-02505269v1
|